Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for LAVA Therapeutics NV have a median target of 6.00, with a high estimate of 11.00 and a low estimate of 6.00. The median estimate represents a 305.41% increase from the last price of 1.48.
High | 643.2% | 11.00 |
Med | 305.4% | 6.00 |
Low | 305.4% | 6.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 25, 2024.
Average growth rate | -324.94% |
Average growth rate | +9.44% |
More ▼
Revenue history & estimates in USD
Average growth rate | +561.95% |
Average growth rate | +111.36% |
More ▼